Ginkgo Bioworks Holdings (DNA) Share-based Compensation (2020 - 2026)

Ginkgo Bioworks Holdings (DNA) has 7 years of Share-based Compensation data on file, last reported at $15.9 million in Q1 2026.

• For the quarter ending Q1 2026, Share-based Compensation fell 8.82% year-over-year to $15.9 million; the trailing twelve-month figure through Mar 2026 stood at $77.5 million (down 14.06% YoY), and the FY2025 full-year result was $81.5 million, down 27.41% from the prior year.
• Share-based Compensation for Q1 2026 stood at $15.9 million, down from $21.0 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $652.8 million in Q1 2022 and bottomed at $14.0 million in Q3 2024.
• The 5-year median for Share-based Compensation is $40.8 million (2024), against an average of $139.5 million.
• Peak annual rise in Share-based Compensation reached 553138.14% in 2022, while the deepest fall reached 93.2% in 2022.
• A 5-year view of Share-based Compensation shows it stood at $108.2 million in 2022, then slumped by 60.4% to $42.8 million in 2023, then tumbled by 52.0% to $20.6 million in 2024, then increased by 2.27% to $21.0 million in 2025, then retreated by 24.61% to $15.9 million in 2026.
• The last three Share-based Compensation figures came in at $15.9 million (Q1 2026), $21.0 million (Q4 2025), and $18.1 million (Q3 2025), per Business Quant data.

Peer Comparison